42
Participants
Start Date
September 7, 2010
Primary Completion Date
November 26, 2013
Study Completion Date
November 26, 2013
Ixabepilone
Given IV
Laboratory Biomarker Analysis
Correlative studies
State University of New York Downstate Medical Center, Brooklyn
Stony Brook University Medical Center, Stony Brook
Abington Memorial Hospital, Abington
Sinai Hospital of Baltimore, Baltimore
Virginia Commonwealth University/Massey Cancer Center, Richmond
Duke University Medical Center, Durham
Carolinas Medical Center/Levine Cancer Institute, Charlotte
Memorial University Medical Center, Savannah
Florida Hospital Orlando, Orlando
University of Mississippi Medical Center, Jackson
Riverside Methodist Hospital, Columbus
Lake University Ireland Cancer Center, Mentor
Case Western Reserve University, Cleveland
Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
Hillcrest Hospital Cancer Center, Mayfield Heights
Cleveland Clinic Foundation, Cleveland
Summa Akron City Hospital/Cooper Cancer Center, Akron
Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
Saint Vincent Hospital and Health Care Center, Indianapolis
Lake Huron Medical Center, Port Huron
Saint John Macomb-Oakland Hospital, Warren
Michigan Cancer Research Consortium NCORP, Ann Arbor
Saint Joseph Mercy Hospital, Ann Arbor
Beaumont Hospital-Dearborn, Dearborn
Saint Mary Mercy Hospital, Livonia
Saint John Hospital and Medical Center, Detroit
Saint Joseph Mercy Oakland, Pontiac
Genesys Regional Medical Center, Grand Blanc
Genesys Hurley Cancer Institute, Flint
Hurley Medical Center, Flint
Genesys Regional Medical Center-West Flint Campus, Flint
Saint Mary's of Michigan, Saginaw
Sparrow Hospital, Lansing
Borgess Medical Center, Kalamazoo
Bronson Methodist Hospital, Kalamazoo
West Michigan Cancer Center, Kalamazoo
Allegiance Health, Jackson
Mercy Medical Center-West Lakes, West Des Moines
Iowa Methodist Medical Center, Des Moines
Iowa-Wide Oncology Research Coalition NCORP, Des Moines
Medical Oncology and Hematology Associates-Des Moines, Des Moines
Medical Oncology and Hematology Associates-Laurel, Des Moines
Mercy Medical Center - Des Moines, Des Moines
Iowa Lutheran Hospital, Des Moines
Medical Oncology and Hematology Associates-West Des Moines, Clive
Mercy Cancer Center-West Lakes, Clive
University of Iowa/Holden Comprehensive Cancer Center, Iowa City
University of Wisconsin Hospital and Clinics, Madison
Gundersen Lutheran Medical Center, La Crosse
Avera Cancer Institute, Sioux Falls
Sudarshan K Sharma MD Limted-Gynecologic Oncology, Hinsdale
Northwestern Medicine Cancer Center Warrenville, Warrenville
Rush University Medical Center, Chicago
University of Chicago Comprehensive Cancer Center, Chicago
Good Samaritan Regional Health Center, Mount Vernon
Saint Louis Cancer and Breast Institute-South City, St Louis
Washington University School of Medicine, St Louis
Mercy Hospital Saint Louis, St Louis
Mercy Hospital Joplin, Joplin
Mercy Clinic-Rolla-Cancer and Hematology, Rolla
Cancer Research for the Ozarks NCORP, Springfield
Mercy Hospital Springfield, Springfield
CoxHealth South Hospital, Springfield
Nebraska Methodist Hospital, Omaha
University of Arkansas for Medical Sciences, Little Rock
University of Oklahoma Health Sciences Center, Oklahoma City
Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa
University of Colorado Hospital, Aurora
Saint Alphonsus Cancer Care Center-Boise, Boise
Women's Cancer Center of Nevada, Las Vegas
John Muir Medical Center-Concord Campus, Concord
John Muir Medical Center-Walnut Creek, Walnut Creek
Hartford Hospital, Hartford
Smilow Cancer Hospital Care Center at Saint Francis, Hartford
The Hospital of Central Connecticut, New Britain
Methodist West Hospital, West Des Moines
Cooper Hospital University Medical Center, Camden
Women and Infants Hospital, Providence
Collaborators (1)
NRG Oncology
OTHER
National Cancer Institute (NCI)
NIH